Epidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome

Cleveland Clinic Journal of Medicine

Volumn 69, Issue SUPPL. 2, 2002, Pages

  Watts, Richard A ^a,c   Scott, David G I ^b   Lane, Suzanne E ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; ZAFIRLUKAST;

AGE DISTRIBUTION; ASTHMA; CHURG STRAUSS SYNDROME; CONFERENCE PAPER; CONSENSUS; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; ETHNOLOGY; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; MICROSCOPIC POLYANGIITIS; NEUROPATHY; NORWAY; POLYARTERITIS NODOSA; SEX RATIO; SPAIN; UNITED KINGDOM; VASCULITIS; WEGENER GRANULOMATOSIS; AGED; COMMUNICABLE DISEASE; ENVIRONMENTAL EXPOSURE; EUROPE; INCIDENCE; MICROCIRCULATION; REVIEW; RISK FACTOR;

AGED; CHURG-STRAUSS SYNDROME; COMMUNICABLE DISEASES; ENGLAND; ENVIRONMENTAL EXPOSURE; EUROPE; HUMANS; INCIDENCE; MICROCIRCULATION; RISK FACTORS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0036052096     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.suppl_2.sii84     Document Type: Conference Paper

References (24)

1. Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary. Arthritis Rheum 1990; 33:1135-1136.
2. Rao JK, Allen NB, Pincus TD. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998; 129:345-352.
3. Jeanette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192.
4. Watts RA, Jolliffe VA, Camithers DM, Lockwood CM, Scott DGI. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1996; 39:1208-1212.
5. Watts RA, Lane SE, Bentham G, Scott DGI. Epidemiology of systemic vasculitis (SV) - a ten year study. Arthritis Rheum 2000; 43:422-427.
6. Watts RA, Koldingsnes W, Nossent H, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DGI. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001; 60:1156-1157.
7. McMahon BJ, Heyward WL, Templin DW, et al. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiological features and long term follow up. Hepatology 1989; 9:97-101.
8. El-Reshaid K, Kapoor MM, El-Reshaid W, Madda JP, Varro J. The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis in Kuwait. Nephrol Dial Transplant 1997; 12:1874-1882.
9. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980's-is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J Roy Coll Phys 1990; 24:284-288.
10. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in Northern Norway. Arthritis Rheum 2000; 43:2481-2487.
11. Reveille JD, Goodman RE, Barger BO, et al. Familial polyarteritis nodosa: a serologic and immunogenetic analysis. J Rheumatol 1989; 16:181-185.
12. Tidman M, Olander R, Svalander C, et al. Patients hospitalised because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244:133-141.
13. Nikkari S, Mertsol J, Korvenranta H, et al. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994; 37:1707-1708.
14. Stegeman CA, Cohen Tervaert JW, de Jong PE, et al. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses in Wegener's granulomatosis. N Engl J Med 1996; 335:16-20.
15. Yashiro M, Muse E, Itch-Ihara T, et al. Significantly high regional morbidity of mop-ANCA-related angiitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kid Dis 2000; 35:889-895.
16. Gregorini G, Ferioli A, Donato F, et al. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case control study. Adv Exp Med Biol 1993; 336:435-440.
17. Nuyts GD, van Vlem E, de Vos A, et al. Wegener's granulomatosis is associated with exposure to silicon compounds: a case control study. Nephrol Dial Transplant 1995; 10:1162-1165.
18. Hogan SL, Stately KK, Dooley MA, et al. Silica exposure in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001; 12:134-142.
19. Dona GF, Catch MF, Galleria C, Hoffman DB, Hoffman GS. Wegener's granulomatosis: Role of environmental exposures. Clin Exp Rheumatol 1998; 16:669-674.
20. Nowak R, Lehman H, Flores-Suarez LF, et al. Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. IS J Kidney Dis 1999; 34:364-373.
21. Raynauld J-P, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993; 20:1524-1526.
22. Falk R, Hogan S, Carey T, et al. Clinical course of anti-neutrophil cytoplasmic antibody associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990; 113:656-663.
23. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody positive vasculitis. Arthritis Rheum 2000; 43:405-413.
24. Wechsler M, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117;708-713.